Santiago Burgos-Puentes

Mr. Santiago Burgos-Puentes


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in Life
Verified
Journal Article
Open access
PDF file
SBSantiago Burgos-Puentes
Santiago Burgos-Puentes
AAArturo Avendaño-Estrada
Arturo Avendaño-Estrada
MSMarquiza Sablón-Carrazana
Marquiza Sablón-Carrazana
EREleazar Ramírez
Eleazar Ramírez
AJAndrea Granados Juárez
Andrea Granados Juárez
MRMiguel Angel Avila Rodriguez
Miguel Angel Avila Rodriguez
Several animal models of Alzheimer’s disease have been developed and tested for diagnostic and treatment purposes. [11C]PIB is the gold-standard radiotracer for the detection of Aβ plaque deposits, a hallmark of the disease. This study aimed to evaluate the in vivo detection of Aβ plaques using [11C]PIB microPET imaging across different animal models of Alzheimer’s disease. The study included 3xTg-AD transgenic mice, TgF344-AD transgenic rats and Aβ injection-based rat model. The results showed an age-related increase in [11C]PIB uptake in 3xTg-AD mice, particularly in the midbrain and thalamus. In TgF344-AD rats, differences were also observed compared to WT controls, with the highest values observed in the hippocampus and cortex. In the injection-based model, inoculated rats showed greater uptake in the injection site than SHAM animals. Across all microPET studies, [11C]PIB uptake was consistently higher in females than in their male counterparts. These findings support the value of transgenic and Aβ injection-based models in preclinical research on Aβ plaque deposition and highlight the importance of considering species, model type, sex, and age in experimental design.